Answer
Sexually active women of childbearing potential should use effective contraception, with pregnancy rates below 1%, throughout midostaurin (Rydapt) treatment and for at least 4 months after stopping treatment.
Sources for this answer
- Rydapt 25 mg soft capsulesNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 10Document updated
Sources checked